2024-11-12 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**1. Performance Overview:**

UnitedHealth Group Inc. (UNH) is a leading health insurance and health services company. The company's stock has significantly outperformed the S&P 500 (VOO) over the long term.

| Year       | CAGR | MDD  | Alpha | Beta | Market Cap (B) | Cumulative Return (UNH) | Cumulative Return (VOO) | Return Difference | Relative I격도 |
|------------|------|-------|------|---------------|-------------------|-------------------------|----------------------|-------------------|-------------------|
| 2015-2017  | 118.8% | 12.4% | 88.6% | 0.9 | 202.89 | 319.17 | 142.82 | 176.35 | 71.52 | 
| 2016-2018  | 113.9% | 18.6% | 89.2% | 0.9 | 229.26 |  |  |  |  |
| 2017-2019  | 82.1% | 23.3% | 39.0% | 0.9 | 270.55 |  |  |  |  |
| 2018-2020  | 58.6% | 36.0% | 19.5% | 1.1 | 322.73 |  |  |  |  |
| 2019-2021  | 106.2% | 36.0% | 16.4% | 1.0 | 462.11 |  |  |  |  |
| 2020-2022  | 81.3% | 36.0% | 63.5% | 0.9 | 487.92 |  |  |  |  |
| 2021-2023  | 50.6% | 18.3% | 21.8% | 0.5 | 484.50 |  |  |  |  |
| 2022-2024  | 22.6% | 20.0% | -2.6% | 0.5 | 557.19 |  |  |  |  |

The data shows that UNH has consistently outperformed the S&P 500 across different time periods. The company's alpha, a measure of outperformance compared to the market, has been positive in most periods, indicating its ability to generate excess returns. Beta, which measures volatility relative to the market, has generally been close to 1, suggesting that UNH's stock price moves in line with the broader market.

**2. Recent Price Movement:**

* Closing Price: 615.81
* Last Market: 627.05 
* 5-day Moving Average: 588.55
* 20-day Moving Average: 573.26
* 60-day Moving Average: 582.12

The stock is currently trading above its 5-day, 20-day, and 60-day moving averages, indicating positive momentum. The recent increase in price could be attributed to positive earnings news, although the jump from Last Market to Closing Price is relatively small.

**3. Technical Indicators:**

* RSI: 74.24
* PPO: 0.98
* Delta_Previous_Relative_Divergence: 1.5 (+)
* Expected Return: 26.6% (long-term, over 2 years)

The high RSI value suggests the stock is overbought, indicating potential for a correction. The PPO, which measures the difference between the 12-day and 26-day Exponential Moving Averages, is also high, confirming the overbought signal. The positive delta in relative divergence indicates a short-term upward trend, while the expected return suggests a long-term potential for outperformance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date       | EPS | Revenue |
|------------|-----|----------|
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2024-08-09 | 4.58 | 98.86 B$ |
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2024-11-04 | 6.31 | 92.36 B$ |

UNH has consistently reported strong earnings growth in recent quarters, exceeding analyst expectations. The company's revenue has also been steadily increasing, driven by growth in its health insurance and healthcare services businesses. This positive trend suggests a healthy future outlook for the company. 

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|----------------|
| 2024-09-30 | $99.18B | 21.56% |
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |

UNH has maintained a consistent profitability margin, suggesting that the company is effectively managing its expenses and generating strong profits. 

**2) Capital and Profitability:**

| Quarter  | Equity    | ROE |
|---------|-----------|-----|
| 2024-09-30 | $94.53B | 6.41% |
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |

UNH has a strong capital base, with a significant amount of equity. The ROE (Return on Equity) is generally positive, suggesting that the company is effectively utilizing its capital to generate profits.

**6. News and Recent Issues:**

* Recent Earnings Release: UNH exceeded analyst expectations for both earnings and revenue in its most recent quarter, further solidifying its position as a leader in the healthcare industry.
* Market Outlook: According to FINBOLD, several analysts have maintained "buy" or "strong buy" recommendations on UNH, citing the company's consistent performance and its strong position in a growing market. 
* Analyst Opinions:  Overall, the market outlook for UNH remains positive. Analysts are confident in the company's long-term growth prospects and its ability to navigate the challenges of the healthcare industry.

**7. Overall Analysis:**

UNH is a well-established company with a strong financial track record, consistently exceeding market expectations. The stock has outperformed the S&P 500 significantly over the long term and currently exhibits positive momentum. While the stock might be overbought, the long-term growth prospects and the expected return remain promising. Its recent earnings report and positive analyst opinions reinforce the company's positive outlook. Based on its financial performance and industry position, UNH is a solid investment option for investors seeking long-term growth. 
